Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6HL9

Crystal Structure of the CsiD Glutarate Hydroxylase in complex with Succinate

Summary for 6HL9
Entry DOI10.2210/pdb6hl9/pdb
DescriptorGlutarate 2-hydroxylase, FE (II) ION, SUCCINIC ACID, ... (4 entities in total)
Functional Keywordsjelly roll, glutarate hydroxylase, alpha-ketoglutarate-dependent, hydrolase
Biological sourceEscherichia coli (strain K12)
Total number of polymer chains2
Total formula weight81641.48
Authors
Williams, R.M.,Mayans, O.,Hartig, J.S. (deposition date: 2018-09-10, release date: 2019-02-20, Last modification date: 2024-02-07)
Primary citationKnorr, S.,Sinn, M.,Galetskiy, D.,Williams, R.M.,Wang, C.,Muller, N.,Mayans, O.,Schleheck, D.,Hartig, J.S.
Widespread bacterial lysine degradation proceeding via glutarate and L-2-hydroxyglutarate.
Nat Commun, 9:5071-5071, 2018
Cited by
PubMed Abstract: Lysine degradation has remained elusive in many organisms including Escherichia coli. Here we report catabolism of lysine to succinate in E. coli involving glutarate and L-2-hydroxyglutarate as intermediates. We show that CsiD acts as an α-ketoglutarate-dependent dioxygenase catalysing hydroxylation of glutarate to L-2-hydroxyglutarate. CsiD is found widespread in bacteria. We present crystal structures of CsiD in complex with glutarate, succinate, and the inhibitor N-oxalyl-glycine, demonstrating strong discrimination between the structurally related ligands. We show that L-2-hydroxyglutarate is converted to α-ketoglutarate by LhgO acting as a membrane-bound, ubiquinone-linked dehydrogenase. Lysine enters the pathway via 5-aminovalerate by the promiscuous enzymes GabT and GabD. We demonstrate that repression of the pathway by CsiR is relieved upon glutarate binding. In conclusion, lysine degradation provides an important link in central metabolism. Our results imply the gut microbiome as a potential source of glutarate and L-2-hydroxyglutarate associated with human diseases such as cancer and organic acidurias.
PubMed: 30498244
DOI: 10.1038/s41467-018-07563-6
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon